Cho‐Ming Chao

2.1k total citations
41 papers, 1.3k citations indexed

About

Cho‐Ming Chao is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Cho‐Ming Chao has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Cho‐Ming Chao's work include Neonatal Respiratory Health Research (31 papers), Congenital Diaphragmatic Hernia Studies (22 papers) and Fibroblast Growth Factor Research (4 papers). Cho‐Ming Chao is often cited by papers focused on Neonatal Respiratory Health Research (31 papers), Congenital Diaphragmatic Hernia Studies (22 papers) and Fibroblast Growth Factor Research (4 papers). Cho‐Ming Chao collaborates with scholars based in Germany, United States and China. Cho‐Ming Chao's co-authors include Savério Bellusci, Harald Ehrhardt, Tayyab Shahzad, Elie El Agha, Parviz Minoo, Alena Moiseenko, Rory E. Morty, Susanne Herold, Jennifer Quantius and Judith Behnke and has published in prestigious journals such as PLoS ONE, Development and PEDIATRICS.

In The Last Decade

Cho‐Ming Chao

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cho‐Ming Chao Germany 17 770 620 482 120 82 41 1.3k
Steffen Kunzmann Germany 23 579 0.8× 250 0.4× 239 0.5× 37 0.3× 32 0.4× 63 1.2k
Mala R. Chinoy United States 19 516 0.7× 411 0.7× 275 0.6× 16 0.1× 51 0.6× 43 838
Furquan Shaheen Canada 19 657 0.9× 179 0.3× 505 1.0× 33 0.3× 47 0.6× 25 1.5k
Tracy X. Cui United States 15 220 0.3× 157 0.3× 422 0.9× 19 0.2× 81 1.0× 23 1.0k
Caroline Sandén Sweden 16 303 0.4× 460 0.7× 151 0.3× 54 0.5× 99 1.2× 28 1.3k
E. K. Weir United States 15 409 0.5× 243 0.4× 315 0.7× 103 0.9× 134 1.6× 33 1.1k
Hisako Endo Japan 19 177 0.2× 168 0.3× 259 0.5× 63 0.5× 82 1.0× 51 887
Jacek J Pietrzyk Poland 18 403 0.5× 201 0.3× 228 0.5× 16 0.1× 122 1.5× 112 1.1k
Bruno Costes France 22 1.1k 1.5× 175 0.3× 512 1.1× 344 2.9× 201 2.5× 40 1.9k
Júlia Hoffmann Germany 20 632 0.8× 257 0.4× 265 0.5× 61 0.5× 42 0.5× 44 1.2k

Countries citing papers authored by Cho‐Ming Chao

Since Specialization
Citations

This map shows the geographic impact of Cho‐Ming Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho‐Ming Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho‐Ming Chao more than expected).

Fields of papers citing papers by Cho‐Ming Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho‐Ming Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho‐Ming Chao. The network helps show where Cho‐Ming Chao may publish in the future.

Co-authorship network of co-authors of Cho‐Ming Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Cho‐Ming Chao. A scholar is included among the top collaborators of Cho‐Ming Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho‐Ming Chao. Cho‐Ming Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strumann, Christoph, et al.. (2025). The long-term tolerability of BNT162b2 in children and adolescents (The CoVacU18 Study). Deutsches Ärzteblatt international. 122(10). 257–263.
2.
Shahzad, Tayyab, Ying Dong, J. M. Brandner, et al.. (2024). Anti-CCL2 therapy reduces oxygen toxicity to the immature lung. Cell Death Discovery. 10(1). 311–311. 2 indexed citations
3.
Armann, Jakob, Uta Behrends, Reinhard Berner, et al.. (2023). Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality. Infection. 51(5). 1357–1367. 9 indexed citations
4.
Schwerk, Nicolaus, Matthias Griese, Peter Florian, et al.. (2023). Severe Neonatal Interstitial Lung Disease Caused by a Rare Surfactant Protein C Mutation. PEDIATRICS. 151(6).
5.
Marega, Manuela, et al.. (2023). Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia. International Journal of Molecular Sciences. 24(13). 11229–11229. 7 indexed citations
6.
Shahzad, Tayyab, Cho‐Ming Chao, Stefan Hadžić, et al.. (2022). TRAIL protects the immature lung from hyperoxic injury. Cell Death and Disease. 13(7). 614–614. 8 indexed citations
7.
Ahmadvand, Negah, Chong Lei, Jin Wu, et al.. (2022). FGFR2b signalling restricts lineage-flexible alveolar progenitors during mouse lung development and converges in mature alveolar type 2 cells. Cellular and Molecular Life Sciences. 79(12). 609–609. 6 indexed citations
8.
Chao, Cho‐Ming, et al.. (2022). Pathophysiological Concepts and Management of Pulmonary Manifestation of Pediatric Inflammatory Bowel Disease. International Journal of Molecular Sciences. 23(13). 7287–7287. 5 indexed citations
9.
Toepfner, Nicole, et al.. (2022). Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years. JAMA Network Open. 5(10). e2237140–e2237140. 7 indexed citations
10.
Chao, Cho‐Ming, et al.. (2021). The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial. Harm Reduction Journal. 18(1). 122–122. 6 indexed citations
11.
Shrestha, Amit, Barry R. Stripp, Françoise Helmbacher, et al.. (2019). Characterization of Tg(Etv4-GFP) and Etv5RFP Reporter Lines in the Context of Fibroblast Growth Factor 10 Signaling During Mouse Embryonic Lung Development. Frontiers in Genetics. 10. 178–178. 16 indexed citations
12.
Yuan, Tingting, Thomas Volckaert, Elizabeth F. Redente, et al.. (2019). FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury. Stem Cell Reports. 12(5). 1041–1055. 73 indexed citations
13.
Chao, Cho‐Ming, Soula Danopoulos, Gianni Carraro, et al.. (2019). A Comprehensive Analysis of Fibroblast Growth Factor Receptor 2b Signaling on Epithelial Tip Progenitor Cells During Early Mouse Lung Branching Morphogenesis. Frontiers in Genetics. 9. 746–746. 34 indexed citations
14.
15.
Volckaert, Thomas, Tingting Yuan, Cho‐Ming Chao, et al.. (2017). Fgf10-Hippo Epithelial-Mesenchymal Crosstalk Maintains and Recruits Lung Basal Stem Cells. Developmental Cell. 43(1). 48–59.e5. 87 indexed citations
16.
Chao, Cho‐Ming, et al.. (2017). Cystic Fibrosis. Deutsches Ärzteblatt international. 114(33-34). 564–574. 38 indexed citations
17.
Shahzad, Tayyab, et al.. (2016). Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. PubMed. 3(1). 23–23. 104 indexed citations
18.
Chao, Cho‐Ming, Elie El Agha, Caterina Tiozzo, Parviz Minoo, & Savério Bellusci. (2015). A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia. Frontiers in Medicine. 2. 27–27. 53 indexed citations
19.
Rochais, Francesca, Rachel Sturny, Cho‐Ming Chao, et al.. (2014). FGF10 promotes regional foetal cardiomyocyte proliferation and adult cardiomyocyte cell-cycle re-entry. Cardiovascular Research. 104(3). 432–442. 57 indexed citations
20.
Agha, Elie El, Susanne Herold, Denise Al Alam, et al.. (2013). Fgf10 -positive cells represent a progenitor cell population during lung development and postnatally. Development. 141(2). 296–306. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffen Kunzmann Breakdown of academic impact, for papers by Mala R. Chinoy Breakdown of academic impact, for papers by Furquan Shaheen Breakdown of academic impact, for papers by Tracy X. Cui Breakdown of academic impact, for papers by Caroline Sandén Breakdown of academic impact, for papers by E. K. Weir Breakdown of academic impact, for papers by Hisako Endo Breakdown of academic impact, for papers by Jacek J Pietrzyk Breakdown of academic impact, for papers by Bruno Costes Breakdown of academic impact, for papers by Júlia Hoffmann
Rankless by CCL
2026